Detalhe da pesquisa
1.
Real-World Experience of Vismodegib in Advanced Basal Cell Carcinoma at a Canadian Cancer Center.
J Cutan Med Surg
; 26(2): 143-148, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34663118
2.
Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma.
Oncologist
; 21(10): 1218-1229, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27511905
3.
Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a randomized, double-blind safety study comparing cetuximab produced from two manufacturing processes using the EXTREME study regimen.
BMC Cancer
; 16: 19, 2016 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26768732
4.
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial.
Nat Med
; 29(8): 2121-2132, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414899
5.
A phase I study of temsirolimus and metformin in advanced solid tumours.
Invest New Drugs
; 30(2): 647-52, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20978924
6.
Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma.
Curr Oncol
; 29(3): 1501-1513, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35323326
7.
Two-year results of a randomised trial comparing 4- versus 12-weekly bone-targeted agent use in patients with bone metastases from breast or castration-resistant prostate cancer.
J Bone Oncol
; 30: 100388, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34567960
8.
A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer.
Eur J Cancer
; 142: 132-140, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33023785
9.
Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218).
Melanoma Res
; 31(1): 67-75, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33234846
10.
Early experience with chemotherapy intensification for poor-prognosis metastatic germ cell cancer and unfavorable tumor marker decline.
Can Urol Assoc J
; 14(2): 43-47, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31348750
11.
Primary Mediastinal Germ Cell Tumors-The University of Western Ontario Experience.
Curr Oncol
; 28(1): 78-85, 2020 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33704177
12.
A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases.
BMC Cancer
; 9: 156, 2009 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19457245
13.
Author Correction: Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial.
Nat Med
; 30(2): 604, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37923839
14.
The Canadian Uro-Oncology Group multicentre phase II study of docetaxel administered every 3 weeks with prednisone in men with metastatic hormone-refractory prostate cancer progressing after mitoxantrone/prednisone.
BJU Int
; 102(5): 551-5, 2008 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-18510661
15.
Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer.
Can Urol Assoc J
; 11(1-2): 24-30, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28443140
16.
Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.
J Clin Oncol
; 34(30): 3655-3663, 2016 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27601543
17.
A randomized phase II and pharmacokinetic study of the antisense oligonucleotides ISIS 3521 and ISIS 5132 in patients with hormone-refractory prostate cancer.
Clin Cancer Res
; 8(8): 2530-5, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12171880
18.
Understanding participation in a trial comparing cryotherapy and radiation treatment.
Can J Urol
; 12(2): 2607-13, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15877944
19.
A phase 2, multicenter, open-label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma.
Cancer Med
; 4(5): 643-50, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25533314
20.
Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Clin Genitourin Cancer
; 13(2): e79-85, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25450036